A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

NCT06057038 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

BIOLOGICAL: GEN1042
DRUG: Pembrolizumab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: 5-Fluorouracil

Sponsor

Genmab

Collaborators

[object Object]